Anderson JM,.Etches D. Prevention and management of postpartum hemorrhage. American Family Physician 2007;75:875-82. [LINK]

Bechard dS. [Use of misoprostol in gynecology and obstetrics]. Gynecol.Obstet.Fertil. 2002;30:317-24. [LINK]

 

 

El Refaey H,.Rodeck C. Post-partum haemorrhage: definitions, medical and surgical management. A time for change. Br.Med.Bull. 2003;67:205-17. [LINK]

 

Goldberg AB, Greenberg MB, Darney PD. Drug therapy: Misoprostol and pregnancy. New England Journal of Medicine 2001;344:38-47. [LINK]

Hofmeyr GJ, Walraven G, Gulmezoglu AM, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG. 2005;112:547-53. [LINK]

Jadesimi A,.Okonofua FE. Tackling the unacceptable: Nigeria approves misoprostol for postpartum haemorrhage. J.Fam.Plann.Reprod.Health Care 2006;32:213-4. [LINK]

Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006. Int.J.Gynaecol.Obstet. 2006;94:243-53. [LINK]

Langer B, Boudier E, Haberstich R, Dreyfus M. [Obstetrical management in the event of persistent or worsening postpartum hemorrhage despite initial measures]. J.Gynecol.Obstet.Biol.Reprod.(Paris) 2004;33:4S73-9. [LINK]

Lokugamage AU, Refaey HE, Rodeck CH. Misoprostol and pregnancy: ever-increasing indications of effective usage. Curr.Opin.Obstet.Gynecol. 2003;15:513-8. [LINK]

Miller S, Lester F, Hensleigh P. Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. J.Midwifery Womens Health 2004;49:283-92. [LINK]

Mousa HA,.Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane.Database.Syst.Rev. 2003;CD003249. [LINK]

Tessier V,.Pierre F. [Risk factors of postpartum hemorrhage during labor and clinical and pharmacological prevention]. J.Gynecol.Obstet.Biol.Reprod.(Paris) 2004;33:4S29-56. [LINK]

Zust S, Hosli I, Surbek D, Holzgreve W. [Adverse effects of misoprostol in pregnancy]. Z.Geburtshilfe Neonatol. 2001;205:43-8. [LINK]

 

Hofmeyr GJ, Ferreira S, Nikodem VC, Mangesi L, Singata M, Jafta Z et al. Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]. BMC.Pregnancy.Childbirth. 2004;4:16. [LINK]

Lokugamage AU, Sullivan KR, Niculescu I, Tigere P, Onyangunga F, El Refaey H et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstet.Gynecol.Scand. 2001;80:835-9. [LINK]

Rogers MS, Yuen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet.Gynecol.Scand. 2007;86:48-54. [LINK]

Schaff EA, DiCenzo R, Fielding SL. Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception 2005;71:22-5. [LINK]

Walraven G, Dampha Y, Bittaye B, Sowe M, Hofmeyr J. Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial. BJOG. 2004;111:1014-7. [LINK]

Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG. 2005;112:1277-83. [LINK]

 

Abdel-Aleem H, El Nashar I, Abdel-Aleem A. Management of severe postpartum hemorrhage with misoprostol. Int.J.Gynaecol.Obstet. 2001;72:75-6. [LINK]

Adekanmi OA, Purmessur S, Edwards G, Barrington JW. Intrauterine misoprostol for the treatment of severe recurrent atonic secondary postpartum haemorrhage. BJOG. 2001;108:541-2. [LINK]

Baruah M. Cohn GM. Efficacy of rectal misoprostol as second-line therapy for the treatment of primary postpartum hemorrhage. Journal of Reproductive Medicine. 53(3):203-6, 2008 Mar.

Bjornerem A, Acharya G, Oian P, Maltau JM. [Postpartum hemorrhage--prophylaxis and treatment in Norway]. Tidsskr.Nor Laegeforen. 2002;122:2536-7. [LINK]

Choo WL, Chua S, Chong YS, Vanaja K, Oei PL, Ho LM et al. Correlation of change in uterine activity to blood loss in the third stage of labour. Gynecol.Obstet.Invest 1998;46:178-80. [LINK]

de Vaate AB, Coleman R, Manneh H, Walraven G. Knowledge, attitudes and practices of trained traditional birth attendants in the Gambia in the prevention, recognition and management of postpartum haemorrhage. Midwifery 2002;18:3-11. [LINK]

Li YT, Yin CS, Chen FM. Rectal administration of misoprostol for the management of retained placenta--a preliminary report. Zhonghua Yi.Xue.Za Zhi.(Taipei) 2001;64:721-4. [LINK]

Nikolov A, Dimitrov A, Krusteva K, Tsankova M. [The efficacy of the misoprostol in cases of abnormal and pathologic hypotonic hemorrhage in the early puerperium]. Akush.Ginekol.(Sofiia) 2006;45:16-9. [LINK]

O'Brien P, El Refaey H, Gordon A, Geary M, Rodeck CH. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet.Gynecol. 1998;92:212-4. [LINK]

Oboro VO, Tabowei TO, Bosah JO. Intrauterine misoprostol for refractory postpartum hemorrhage. Int.J.Gynaecol.Obstet. 2003;80:67-8. [LINK]

Ozan H, Bilgin T, Ozsarac N, Ozerkan K, Cengiz C. Misoprostol in uterine atony: a report of 2 cases. Clin.Exp.Obstet.Gynecol. 2000;27:221-2. [LINK]

Prata N, Mbaruku G, Campbell M, Potts M, Vahidnia F. Controlling postpartum hemorrhage after home births in Tanzania. Int.J.Gynaecol.Obstet. 2005;90:51-5. [LINK]

Shojai R, Piechon L, d'Ercole C, Boubli L, Ponties JE. [Rectal administration of misoprostol for delivery induced hemorrhage. Preliminary study]. J.Gynecol.Obstet.Biol.Reprod.(Paris) 2001;30:572-5. [LINK]

Shojai R, Desbriere R, Dhifallah S, Courbiere B, Ortega D, d'Ercole C et al. [Rectal misoprostol for postpartum hemorrhage]. Gynecol.Obstet.Fertil. 2004;32:703-7. [LINK]

 

 

Bradley SE, Prata N, Young-Lin N, Bishai DM. Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings. Int.J.Gynaecol.Obstet. 2007;97:52-6. [LINK]

Schaff EA, DiCenzo R, Fielding SL. Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception 2005;71:22-5. [LINK]

Zust S, Hosli I, Surbek D, Holzgreve W. [Adverse effects of misprostol in pregnancy]. Z.Geburtshilfe Neonatol. 2001;205:43-8. [LINK]

Potts M,.Campbell M. Three meetings and fewer funerals--misoprostol in postpartum haemorrhage. Lancet 2004;364:1110-1. [LINK]

Olufowobi O, Afnan M, Sorinola O, Papaioannou S, Sharif K. A randomized study comparing rectally administered misoprostol versus syntometrine combined with an oxytocin infusion for the cessation of primary postpartum hemorrhage (letter). Acta Obstet.Gynecol.Scand. 2002;81:993. [LINK]

Lokugamage AU, Sullivan KR, Moodley J, Rodeck CH. Misoprostol for the treatment of postpartum hemorrhage (authors’ response). Acta Obstetricia et Gynecologica Scandinavica 2002;81:994. [LINK]

Ramsey PS,.Ramin KD. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study (letter). Obstet.Gynecol. 1999;93:157-8. [LINK]

 

O'Brien P. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: A descriptive study. Authors’ response). Obstetrics and Gynecology 1999;93:157-8. [LINK]

 

 

Disclaimer & Copyright | About this Site & Contact Details Information auf Deutsch | Informacion en Español

Search